China Medical System Holdings Limited (HKG:0867)
10.38
+0.06 (0.58%)
Oct 14, 2026, 4:08 PM HKT
China Medical System Holdings Employees
China Medical System Holdings had 6,415 employees as of December 31, 2025. The number of employees increased by 274 or 4.46% compared to the previous year. That makes China Medical System Holdings the 4,702nd largest employer in the world and 389th in Hong Kong.
Employees
6,415
Change (1Y)
274
Growth (1Y)
4.46%
Revenue / Employee
1.57M HKD
Profits / Employee
276.03K HKD
Market Cap
25.26B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6,415 | 274 | 4.46% |
| Dec 31, 2024 | 6,141 | 440 | 7.72% |
| Dec 31, 2023 | 5,701 | 54 | 0.96% |
| Dec 31, 2022 | 5,647 | 355 | 6.71% |
| Dec 31, 2021 | 5,292 | 920 | 21.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| China Resources Pharmaceutical Group | 84,000 |
| The United Laboratories International Holdings | 18,000 |
| Grand Pharmaceutical Group | 12,326 |
| Simcere Pharmaceutical Group | 7,064 |
| Shandong Xinhua Pharmaceutical Company | 7,015 |
| Sunshine Lake Pharma | 6,299 |
| Consun Pharmaceutical Group | 2,847 |
| CanSino Biologics | 1,175 |
China Medical System Holdings News
- 5 weeks ago - CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD) - GlobeNewsWire
- 1 month ago - China Medical System Holdings Earnings release: H1 2026 - Filings
- 7 months ago - China Medical System Holdings Annual report: H2 2025 - Filings
- 7 months ago - China Medical System Holdings Earnings release: H2 2025 - Filings
- 7 months ago - China Medical System reports NMPA acceptance of ruxolitinib phosphate cream NDA - TheFly
- 10 months ago - China Medical says povorcitinib included in Breakthrough Therapeutic Drugs list - TheFly
- 10 months ago - CMS (867.HK/8A8.SG): Innovative Drug Oral JAK1 Inhibitor Povorcitinib Has Been Included in the List of Breakthrough Therapeutic Drugs in China - GlobeNewsWire
- 10 months ago - China Medical System announces NMPA acceptance of Y-3 NDA - TheFly